Sclerotherapy is a minimally invasive procedure where a special solution is injected directly into vascular or lymphatic lesions—such as recurrent cysts, lymphangiomas, hemangiomas, or low-flow vascular malformations. The solution irritates the lining of the vessels or cysts, causing them to collapse and gradually be absorbed.

Who Is It For?

This treatment is ideal for patients with:

• Recurrent cystic lesions, including lymphatic (lymphangiomas) and blood vessel growths (hemangiomas)
• Low‑flow vascular malformations (e.g. venous or lymphatic) causing discomfort, swelling, or occasional bleeding
• People wanting a non-surgical, image-guided option instead of excision

Key Benefits:

• Targeted, image-guided injections using ultrasound or fluoroscopy
• No general anesthesia—performed in a minor procedure setting
• Sclerosant solutions (bleomycin, doxycycline, polidocanol) induce controlled vessel closure
• Typically safe and effective—especially for cystic and macrocystic lesions

Common Uses:

• Lymphangiomas (cystic hygromas), especially in head/neck region
• Hemangiomas, particularly when surgery is difficult
• Low-flow vascular malformations, including venous or lymphatic malformations